Low antitubercular drug levels in newly infected normal hosts

• Main Authors: Khantipongse J., Nambunmee K., Siri S., Pokaewa P., Phothirat C.
• 格式: Article
• 語言: English
• 出版: 2014
• 在線閱讀: http://www.scopus.com/inward/record.url?eid=2-s2.0-84880651160&partnerID=40&md5=0850c32810a84ee9c8d916549ae60291; http://cmuir.cmu.ac.th/handle/6653943832/4164
• 機構: Chiang Mai University

Background: Low antitubercular drug level is a risk factor for treatment failures. Antitubercular drug level determination has been suggested for complicated tuberculosis patients, but there has been interest in performing such studies in normal hosts. Objective: To identify whether there are advantages of routine antitubercular drug level determination. Patients and Methods: We determined drug levels in 15 new normal host Thai tuberculosis patients by using published methods. All patients received the Directly Observed Treatment Short-course including pyrazinamide, rifampicin, and isoniazid. Results: We started with 15 patients of whom 27% (4 patients) were mycobacteria smear-positive, 33% (5 patients) had low blood levels of pyrazinamide and 87% had low levels of rifampicin. The drug levels in the smear-positive group were lower than in the smear-negative group. All smear-positive patients had a rifampicin levels lower than the therapeutic range. Conclusion: Antitubercular drug level determination has a potential to identify patients who may be at risk of poor treatment results.